A 7-year-old female child was presented to the emergency room with acute abdominal pain and vaginal bleeding. Her assessment revealed a firm large lower abdominal mass with evidence of precocious puberty with bilaterally symmetrically enlarged breast (Tanner stage B4-P1-A1). Abdominal imaging showed a well-defined soft midline pelvi-abdominal single mass measuring 7.0 × 12.6 × 11.7 cms with no ascites. Serum tumour markers including lactate dehydrogenase (LDH), beta-subunit of human chorionic gonadotropin (B-hCG) and luteinizing hormone/follicular stimulating hormone (LH/FSH) were all normal. At operation, there was a huge abdominal tumour weighing 558 grams, localized to the right ovary sparing the left ovary, uterus, lymph nodes and other abdominal organs. Unilateral right salpingo-oophorectomy was performed. Histopathologic examination revealed ovarian dysgerminoma with intact capsule; FIGO Ia. Immunohistochemical stainings were positive for placental alkaline phosphatase (PALP), CD 117(c-kit) and calretinin focally but was negative for cancer antigen-125 (CA-125), B-hCG, S-100, carcinoembryonic antigen (CEA), and leukocyte common antigen (LCA). Being fitting in the low risk classification, the wait and see protocol was selected with strict follow-up with pediatric oncologist and pediatric surgeon. Along the duration of 2 years follow up, there was no more vaginal bleeding with dramatic reduction of the breast size and no recurrence.
INTRODUCTION
Germinomas include the malignant germ cell tumours of childhood that are usually found in the ovaries (dysgerminoma), in the pineal region, and in the mediastinum. [1] In females, dysgerminoma is the most common malignant germ cell tumour of the ovary and represents only 2% of all ovarian cancers. [1] This diagnosis is even more uncommon in the pediatric age group with incidence of 1/80000. [2] Elevation of serum lactate-dehydrogenase ( L D H ) , c a n c e r -a n t i g e n -1 2 5 ( C A -1 2 5 ) , beta-subunit-human-chorionic-gonadotrophin (B-hCG), S-100-protein, neurone-specific-enolase (NSE), and placental-alkaline-phosphatase (PALP) are the frequent findings in patients with germinomas. [1] We present a pediatric patient with an ovarian dysgerminoma who have a unique finding of normal serum tumour markers levels, and a very odd presentation of precocious puberty.
CASE REPORT
A 7-year-old female child presented with severe recurrent attacks of acute abdominal pain and massive vaginal bleeding. Examination revealed firm large mobile lower abdominal mass, 13 × 12 cm 2 , with associated evidence of precocious puberty with bilaterally symmetrically enlarged breast (Tanner stage B4 P1 A1), [ Figure 1 ]. Otherwise, body system review was normal including perineum and per rectal (P/R) examination.
Abdominal ultrasonography and computed tomography showed a well-defined soft midline pelvi-abdominal single mass, 7.0 × 12.6 × 11.7 cm 3 , with remarkable increased surrounding vascularity and low resistance internal vascularity. The mass appeared inseparable from the right ovary with non-visualization of the right ovary. It was extending anteriorly to the anterior abdominal wall, posteriorly to the para-vertebral muscles with compression of both ureters, and inferiorly to the urinary bladder with displacement of intestinal loops on both sides [ Figure 2 ]. The uterus appeared separable from the mass but was seen abnormally bulky for the age of the patient, with endometrial thickness 6-7 mm, with internal echogenic mass, possibly bleeding. Pelvi-calyceal system was mildly dilated on both sides with mildly dilated proximal right ureter. No ascites was detected. The study was otherwise normal with no definite evidence of direct invasion or lymph node enlargement. Serum levels of various tumour markers such as LDH, alpha-feto-protein (AFP), Beta-hCG, FSH/LH, and estradiol were surprisingly normal. Karyotyping revealed a normal female; 46XX.
Surgery was performed via a pfannestiel incision. The main tumour arose from the right ovary [ Figure 2 ], sparing the left ovary, the uterus, the abdominal lymph nodes and other abdominal organs [ Figure 2 ]. Unilateral right simple salpingo-oophorectomy was performed.
On pathological examination, the cut surface of the tumour was solid, tan, and lobulated with intact capsule. On histopathology [ Figure 3 ], there were large aggregates and cords of uniform cells surrounded by strands of connective tissue containing variable amount lymphoid cells. The tumour cells were large oval or rounded with little clear cytoplasm and large rounded centrally located vesicular nuclei with fine chromatin and eosinophilic nucleoli. Mitotic figures were abundant with the presence of atypical forms. Lymphovesicular invasion was present. These histopathologic findings confirmed the diagnosis of ovarian dysgerminoma. The right fallopian tube was normal by histopathological assessment. Figure 3 ], for PALP (rabbit-polyclonal-anti-PALP-antibody, Nichirei, Japan), focal reactivity to calretinin, CD 117 (c kit), and LMW-cytokeratin focally with negative staining for CA-125 (mouse-monoclonal-anti-CA-125-antibody, Immunotech, France), B-hCG (mouse-monoclonal-antibody-anti-B-hCG, Nichirei, Japan), S-100 (rabbit-polyclonal-anti-S-100-antibody, Zymed), alpha fetoprotein (AFP), CD-30, HMW-cytokeratin, carcino-embryonic antigen (CEA), and leukocyte common antigen (LCA).
T h e t u m o u r c e l l s e x h i b i t e d h i g h l y p o s i t i v e immunohistochemical staining [
The tumour was fitting with the stage Ia of the International Federation of Gynecology and Obstetrics classification (FIGO Ia) which was considered low risk and candidate for the wait and see strategy by most of the oncology groups. Pediatric oncology consultation with conjoint pediatric surgeon and parental opinion agreed for not starting postoperative chemo-or radiotherapy management and planned for strict follow-up. After about 2 years of follow up, the breast size decreased dramatically to normal with cessation of bleeding and no evidence of recurrence.
DISCUSSION
Ovarian tumours are rare in the pediatric age group, but represent nearly 50% of all ovarian masses; 90% are benign [3] and germ cell tumours represent the most frequent histological type in this population (60-70%), with teratoma as the main form. [4] Dysgerminomas are rare but are among the most frequent malignant germ cell tumours in girls. [5] The incidence in the pediatric population is not well known and only rare case reports are found in the pediatric literature. [5] Most patients with dysgerminomas, present with either non-specific symptoms, [6] or most commonly with abdominal pain and pelvic/abdominal mass. [7] Similarly, the reported patient presented with abdominal pain and pelvi-abdominal mass but with a very rare association which is vaginal bleeding with precocious puberty which occurs mostly in non-malignant tumours like juvenile-granulosa-cell tumours not dysgerminaomas.
Ovarian dysgerminoma with precocious puberty presentation is very unlikely. [8] In that respect, we greatly matched with Song and co-workers, [8] who reported ovarian dysgerminoma in a 6-year-old female with precocious puberty but with high serum tumour markers unlike to us. Ovarian dysgerminoma is usually hormonally inert, but when it contains syncytiotrophoblastic giant cells or undergoes malignant transformation, the level of estradiol might be elevated. [8] Elevation of serum LDH, CA-125, B-hCG, PALP, and NSE are frequent findings in patients with germinomas. [1] However, our patient was unique in having negative results for all serum tumour markers, an observation, that is very unlikely to find.
In dysgerminomas, diagnosis is usually confirmed by positive immunohistochemical staining for LDH, CA-125, B-hCG, PALP, NSE, cytokeratin 18, and S-100 protein. [1] About 5% of dysgerminomas are found in girls with chromosomal abnormalities such as 46XY (testicular-feminization or Sweyer-syndrome) or 45X/46XY mosaic. Therefore, in cases of pre-pubertal pelvic masses, karyotyping should be carried out. Karyotyping was done in our patient and revealed a normal female, 46XX.
Accurate surgical staging is essential to properly ascertain the correct risk-based treatment. [9] The FIGO classification is the most accepted. [10] The German children cancer registry has been registering their patients since 1980s and Gobel et al. published their results using the MAIKEI protocols. [11] They settled a protocol in which the indication for primary tumour resection and a supplementary radiotherapy, or, in selected cases, primary chemotherapy and delayed tumour resection after the spreading, has been graded. [11] The described patient fits into FIGO Ia which is candidate for surgical excision and the wait and see strategy. Higher FIGO scores must receive chemotherapy. [10] Although dysgerminoma is bilateral in 10-15% of cases, [3] we performed simple right salpingo-oophorectomy without taking biopsy from the other unaffected ovary. The issue of taking biopsy is still controversial. We agree with those who recommend leaving the normal contra-lateral ovary undisturbed aiming to preserve fertility. [12] We believe that the strict frequent follow-up can allow early detection of an occult dysgerminoma in the remaining ovary which can be promptly treated while still in early stage.
Previous reports described that the median follow-up was 127 months-15.9 years and the 10-year survival rate was 81.8-82.9%. [13] In conclusion, dysgerminoma can have different presentations including precocious puberty and normal serum tumour markers. Histopathology and immune-histochemical staining are the gold standard. The aim of management is almost always to preserve fertility in these young females. 
